JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 31 No. 10 1608-1616
© 1990 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaiser, K. P.
Right arrow Articles by Feinendegen, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaiser, K. P.
Right arrow Articles by Feinendegen, L. E.

Tracer Kinetics of 15-(Ortho-123/131I-Phenyl)-Pentadecanoic Acid (oPPA) and 15-(Para-123/131I-Phenyl)-Pentadecanoic Acid (pPPA) in Animals and Man

Klaus P. Kaiser, Bernhard Geuting, Kurt Großmann, Ernst Vester, Benno Lösse, Mohamed A. Antar, Hans-J. Machulla and Ludwig E. Feinendegen

Institute of Medicine, Nuclear Research Center, Jülich, FRG
Department of Cardiology, University of Düsseldorf, Düsseldorf, FRG
Univeristy of Connecticut and VA Medical Center, Newington, Connecticut
Institute of Medical Radiation Physics, University of Essen, FRG

Correspondence: For reprints contact: Prof. Dr. Ludwig E. Feinendegen, Institute of Medicine, Nuclear Research Center, P.O. Box 1913, D-5170 Jülich, West Germany.

ABSTRACT

The human myocardium retains oPPA as opposed to pPPA. Therefore turnover of oPPA was compared with that of pPPA in rat hearts and in man, the latter by using substrates double-labeled with 123/131I and 14C. Moreover, substrate binding to coenzyme-A was tested in vitro. In rats, oPPA remained mainly in the pool of free fatty acids, as opposed to pPPA, which was metabolized by mitochondrial ß-oxidation. Binding to coenzyme-A at maximum was 62% for oPPA, 81% for pPPA and 90% for palmitic acid.

In man, after i.v. and intracoronary injection of double-labeled oPPA, the two radionuclides reappeared together in venous blood and in coronary sinus respectively, in an unchanged ratio but at a significantly lower rate than with pPPA. It can be concluded that oPPA is bound to coenzyme-A and is retained in the cytosolic lipid pool, while pPPA is metabolized by mitochondrial ß-oxidation. A dual-tracer application of oPPA and pPPA has the potential of being a specific probe for the function of the carnitine shuttle.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1990 by the Society of Nuclear Medicine.